drugset / Trial / NCT03040180

Endoscopic Assisted Electrochemotherapy in Addition to Neoadjuvant Treatment of Locally Advanced Rectal Cancer

NCT03040180

RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of neoadjuvant electrochemotherapy on locally advanced rectal cancer (UICC II-III) in an intended curative clinical setting, using an endoscopic electroporation device (EndoVE).

Timeline

Start
2017-01
Primary completion
2019-06
Completion
2019-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Bleomycin Unknown 15000 unknown Intravenous